Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pCMFlag_hsNR0B1 (#RDB06297)

Expression vector of human ACH.

Alternative name SET-0026_126
Clone info. Expression vector of human ADR. Expression was confirmed by Western blotting with anti-FLAG antibody.
Comment Derived from Sugano BC011564. PCR cloning, forward primer: gcgggcgagaaccaccagtg; reverse primer: ttatatctttgtacagagcatttcca.
Vector backbone pCMV_S-FLAG (RDB05956) (Plasmid)
Size of vector backbone 5.5 kb
Selectable markers Amp^r (E. coli), Neo^r (mammalian cell)
Growth conditions 37C, LB+Amp
Gene/insert name Human DAX1;ACH cDNA
Depositor|Developer DNA Bank, |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
MTA, for use for for-profit purpose [Word]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution The RECIPIENT agrees to describe RIKEN BRC as the source of the MATERIAL and cite Gene 200, 149-156, 1997 in any publication.
Additional terms and conditions:
Regrding pRc/CMV:
a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only.
b) LIFE MATERIALS shall not be used for any commercial purposes.
c) LIFE MATERIALS shall not be transferred beyond the specified recipient.
d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
提供同意書 (MTA, 営利目的用)[Word]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 発表に際し、理研BRCから入手したことを明記し、指定する文献(Gene, 200, 149-156 (1997))を引用すること。
付加的使用条件:
pRc/CMVについて:
a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only.
b) LIFE MATERIALS shall not be used for any commercial purposes.
c) LIFE MATERIALS shall not be transferred beyond the specified recipient.
d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above.

Catalog # Resource name Shipping form Fee
RDB06297 pCMFlag_hsNR0B1 DNA solution JPY 9,460 (not-for-profit academic purpose)
JPY 18,920 (for-profit-research purpose)
plus cost of shipping containers, dry ice (if required) and shipping charge

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pCMFlag_hsNR0B1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB06297).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB06297_A3Irp2.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: CMV-Forward
Sequence file: RDB06297_A3Ira.seq check
>06297_06297_A3Ir_CMV-Foward_E11_14.ab1
    1 TGTATCAACT TCCGCCCATT GACGCAAATG GGCGGTAGGC GTGTACGGTG GGAGGTCTAT
   61 ATAAGCAGAG CTCTCTGGCT AACTAGAGAA CCCACTGCTT ACTGGCTTAT CGAAATTAAT
  121 ACGACTCACT ATAGGGAGAC CCAAGCTGAA TTCACCATGG ACTACAAGGA CGATGACGAT
  181 AAGGCGGCCG CGGGCGAGAA CCACCAGTGG CAGGGCAGCA TCCTCTACAA CATGCTTATG
  241 AGCGCGAAGC AAACGCGCGC GGCTCCTGAG GCTCCAGAGA CGCGGCTGGT GGATCAGTGC
  301 TGGGGCTGTT CGTGCGGCGA TGAGCCCGGG GTGGGCAGAG AGGGGCTGCT GGGCGGGCGG
  361 AACGTGGCGC TCCTGTACCG CTGCTGCTTT TGCGGTAAAG ACCACCCACG GCAGGGCAGC
  421 ATCCTCTACA GCATGCTGAC GAGCGCAAAG CAAACGTACG CGGCACCGAA GGCGCCCGAG
  481 GCGACGCTGG GTCCGTGCTG GGGCTGTTCG TGCGGCTCTG ATCCCGGGGT GGGCAGAGCG
  541 GGGCTTCCGG GTGGGCGGCC CGTGGCACTC CTGTACCGCT GCTGCTTTTG TGGTGAAGAC
  601 CACCCGCGGC AGGGCAGCAT CCTCTACAGC TTGCTCACTA GCTCAAAGCA AACGCACGTG
  661 GCTCCGGCAG CGCCCGAGGC ACGGCCAGGG GGCGCGTGGT GGGACCGCTC CTACTTCGCG
  721 CAGAGGCCAG GGGGTAAAGA GGCGCTACCA GGCGGGCGGG CCACGGCGCT TCTGTACCGC
  781 TGCTGCTTTT GCGGTGAAGA CCACCCGCAG CAGGGCAGCA CCCTCTACTG CGTGCCCACG
  841 AGCACAAATC AAGCGCAGGC GGCTCCGGAG GAGCGGCCGA GGGCCCCCTG GTGGGACACC
  901 TCCTCTGGTG CGCTGCGGCC GGTGGCGCTC AAGAGTCCAC AGGTGGTCTG CGAGGCAGCC
  961 TCAGCGGGCC TGTTGAAGAC GCTGCGCTTC GTCAAGTACT TGCCCTGCTT CCAGGTGCTG
 1021 CCCCTGGACC AGCAGCTGGG TGCTGGGTGC GCAACTGCTG GCGTCCCTGC TCATGCTGAG
 1081 CTGGGCCCAG GACCGCTTGC AGATCGAGAC CTGTGAGTCT CGGAGCTCAG CATGCTGCCA
1141 GAAAAGAAAT TCCCTTCCAA CCGAC
//
Primer: SP6
Sequence file: RDB06297_A3Irb.seq check
>06297_06297_A3Ir_Sp6_F11_17.ab1
    1 CCTTTAGTCA TGCCTCGAGC GGCCTTATAT CTTTGTACAG AGCATTTCCA GCATCATATC
   61 ATCCATGCTG ACTGTGCCGA TGATGGGCCT GAAGAACAGT TCAGCAATGA CATTGGCATT
  121 GATGAATCTC AGCAGGAAAA GGGTACTATT AAGTTCGATG AATCTGTCAT GGGGCCCTTG
  181 GTGCGTCATC CTGGTGTGTT CACTGAGTAT TTGCTGAGTT CCCCACTGGA GTCCCTGAAT
  241 GTACTTCACG CACTGCAGGC CCGGCACGTC CGGGTTAAAG AGCACGGTCC CCTTGAGGTA
  301 GGCGTACTCC TTGGTACTGA TGTTCAGACT CCAGCATTTG GAAAGAAAGC ACTTGATGGC
  361 TTGGACCTGG GAGGCGGAGG GCACCTTCCT GGCCTCCGCC GGCGGTGCCA AATGGTGCTG
  421 CAGCGTGGGC ACGGGCAGTG GCTCGTTGCC CCCGGTCTCC CGCCGCCTGG TGGTGAGGAT
  481 CTTCTGCAGC ATGCTGGGCT CCGAGACTTC CACAGTCTCG AACTGCAAGC GGTCCTGGGC
  541 CAGCTCAAGC ATGAGCAGGG ACGCCCAGCA GTTGCGCACC AGCACCAGCT GCTGGTCCAG
  601 GGGCAGCACC TGGAAGCAGG GCAAGTACTT GACGAAGCGC AGCGTCTTCA ACAGGCCCGC
  661 TGAGGCTGCC TCGCAGACCA CCTGTGGACT CTTGAGCGCC ACCGGCCGCA GCGCACCAGA
  721 GGAGGTGTCC CACCAGGGGG CCCTCGGCCG CTCCTCCGGA GCCGCCTGCG CTTGATTTGT
  781 GCTCGTGGGC ACGCAGTAGA GGGTGCTGCC CTGCTGCGGG TGGTCTTCAC CGCAAAAGCA
  841 GCAGCGGTAC AGAAGCGCCG TGGCCCGCCC GCCTGGTAGC GCCTCTTTAC CCCCTGGCCT
  901 CTGCGCGAAG TAGGAGCGGT CCCACCACGC GCCCCCTGGC CGTGCCTCGG GCGCTGCCGG
  961 AGCCACGTGC GTTTGCTTTG AGCTAGTGAG CAAGCTGTAG AGGATGCTGC CCTGCCGCGG
 1021 GTGGGTCTTC ACCACAAAAG CAGCAGCGGG TACAGGGAGT GCCACGGGGC CCGCCCACCC
 1081 CGGGAAGCCC CGCTCTGCCC CAACCCCGGG ATTCAGAGCG CACGAACCAG CTTCAGCACG
1141 GGAACCCAGG CCGAATCGTC ATG
//
Primer: SV40pro_F_V2
Sequence file: RDB06297_A3Irc.seq check
>06297_06297_A3Ir_SV40pro_F_V2_G02_07_ABI08.ab1
    1 GGCACAACCT TTTTTTGGGG GGGGCTTAGG GCTTTTGCAA AAAGCTCCCG GGGAGCTTGG
   61 ATATCCATTT TCGGATCTGA TCAAGAGACA GGATGAGGAT CGTTTCGCAT GATTGAACAA
  121 GATGGATTGC ACGCAGGTTC TCCGGCCGCT TGGGTGGAGA GGCTATTCGG CTATGACTGG
  181 GCACAACAGA CAATCGGCTG CTCTGATGCC GCCGTGTTCC GGCTGTCAGC GCAGGGGCGC
  241 CCGGTTCTTT TTGTCAAGAC CGACCTGTCC GGTGCCCTGA ATGAACTGCA GGACGAGGCA
  301 GCGCGGCTAT CGTGGCTGGC CACGACGGGC GTTCCTTGCG CAGCTGTGCT CGACGTTGTC
  361 ACTGAAGCGG GAAGGGACTG GCTGCTATTG GGCGAAGTGC CGGGGCAGGA TCTCCTGTCA
  421 TCTCACCTTG CTCCTGCCGA GAAAGTATCC ATCATGGCTG ATGCAATGCG GCGGCTGCAT
  481 ACGCTTGATC CGGCTACCTG CCCATTCGAC CACCAAGCGA AACATCGCAT CGAGCGAGCA
  541 CGTACTCGGA TGGAAGCCGG TCTTGTCGAT CAGGATGATC TGGACGAAGA GCATCAGGGG
  601 CTCGCGCCAG CCGAACTGTT CGCCAGGCTC AAGGCGCGCA TGCCCGACGG CGAGGATCTC
  661 GTCGTGACCC ATGGCGATGC CTGCTTGCCG AATATCATGG TGGAAAATGG CCGCTTTTCT
  721 GGATTCATCG ACTGTGGCCG GCTGGGTGTG GCGGACCGCT ATCAGGACAT AGCGTTGGCT
  781 ACCCGTGATA TTGCTGAAGA GCTTGGCGGG CGAAATGGGC CTGACCGCTT CCTCGTGCTT
  841 TACGGTATCG CCGCTCCCGA TTCGCAGCGC ATCGCCTTTC TATCGCCTTT CTTGACGAGG
  901 TTCTTCTGAG CGGGACTCTG GGGGTTCGAA ATGACCGACC AAGCGACGCC CCAACCTGGC
  961 CCATCACGAG ATTTCGATCC ACCCGCCGCC CTTCTATGAA AAGGTTGGGG CTTCGGAAAT
 1021 CGTTTTCCGG GACGCCCGGC CTGGGATGAT CCCTCCCAGC GCGGGGATCT CATGGCTGGG
 1081 AGTTCTTCCG CCCAACCCCG AACTGCTTTA TTGCCAGCCT TATAAATGGG TTACAAGTAA
 1141 AACATAGCCA TCCACCAAAG TTCACCAAAT CAAGCATTTT TTCACTTGCG ATTCCTAGTT
1201 TGGTGGTATT TGTCCCAAAA CTCTCCATCT ACGAACTTGT AGAATCAC
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles